Vered Stearns
1998–2025 年に発表
- 115
- 論文数
- 20,471
- 被引用数
- 76
- h 指数
- 110
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine44.6%
- Biochemistry, Genetics and Molecular Biology43.5%
- Pharmacology, Toxicology and Pharmaceutics3.6%
- Immunology and Microbiology3%
- Computer Science1.1%
- Neuroscience0.8%
- その他3.4%
トピック
- Breast Cancer Treatment Studies8.1%
- Estrogen and related hormone effects4.5%
- Advanced Breast Cancer Therapies3.8%
- Cancer Genomics and Diagnostics3.8%
- HER2/EGFR in Cancer Research3.6%
- Epigenetics and DNA Methylation2.9%
- その他73.3%
共著者
- Antonio C. Wolff28
- Daniel F. Hayes22
- Roisín M. Connolly19
- Eric P. Winer16
- N. Lynn Henry14
- David A. Flockhart13
- Nancy E. Davidson13
- Anna Maria Storniolo12
- John H. Fetting12
- Stacie C. Jeter10
- Elizabeth M. Jaffee9
- Lisa A. Carey9
- Minetta C. Liu9
- Ashley Cimino‐Mathews8
- Clifford A. Hudis8
- Harold J. Burstein8
- Ben Ho Park7
- Deborah K. Armstrong7
- Ian E. Krop7
- Anne Nguyen6
- Cesar A. Santa‐Maria6
- Erica L. Mayer6
- Evanthia T. Roussos Torres6
- James M. Rae6
全論文
- Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update
著者: Fabrice Andre, Nofisat Ismaila, Kimberly H. Allison, William E. Barlow, Deborah E. Collyar, Senthil Damodaran, N. Lynn Henry, Komal Jhaveri, Kevin Kalinsky, Nicole M. Kuderer, Anya Litvak, Erica L. Mayer, Lajos Pusztai, Rachel Raab, Antonio C. Wolff, Vered Stearns - Journal of Clinical Oncology 2022 被引用: 347
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
著者: Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen A. Gelmon, Sharon H. Giordano, Clifford A. Hudis, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2018 被引用: 630
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
著者: Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Eva Ciruelos, Harold J. Burstein, Hervé Bonnefoi, Meritxell Bellet, Silvana Martino, Charles E. Geyer, Matthew P. Goetz, Vered Stearns, Graziella Pinotti, Fabio Puglisi, Simon Spazzapan, Miguel Ángel Climent, Lorenzo Pavesi, Thomas Ruhstaller, Nancy E. Davidson, Robert L. Coleman, Marc Debled, Stefan Buchholz, James N. Ingle, Eric P. Winer, Rudolf Maibach, Manuela Rabaglio, Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673
- Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
著者: Olivia Pagani, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Matthew P. Goetz, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric P. Winer, Barbara Ruepp, Sherene Loi, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan, Prudence A. Francis - Journal of Clinical Oncology 2022 被引用: 154
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer
著者: Ayca Gucalp, Sara M. Tolaney, Steven J. Isakoff, James N. Ingle, Minetta C. Liu, Lisa A. Carey, Kimberly Blackwell, Hope S. Rugo, Lisle M. Nabell, Andres Forero, Vered Stearns, Ashley S. Doane, Michael A. Danso, Mary Ellen Moynahan, Lamia F. Momen, Joseph M. Gonzalez, Arooj Akhtar, Dilip D. Giri, Sujata Patil, Kimberly Feigin, Clifford A. Hudis, Tiffany A. Traina - Clinical Cancer Research 2013 被引用: 740
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
著者: Olivia Pagani, Meredith M. Regan, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Edith A. Perez, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Graziella Pinotti, Fabio Puglisi, Diana Crivellari, Thomas Ruhstaller, Eric P. Winer, Manuela Rabaglio, Rudolf Maibach, Barbara Ruepp, Anita Giobbie‐Hurder, Karen N. Price, Jürg Bernhard, Weixiu Luo, Karin Ribi, Giuseppe Viale, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 被引用: 747
- Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
著者: Roisín M. Connolly, Huili Li, Rachel C. Jankowitz, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon A. Slater, Penny Powers, Antonio C. Wolff, John H. Fetting, Adam Brufsky, Richard Piekarz, Nita Ahuja, Peter W. Laird, Hui Shen, Daniel J. Weisenberger, Leslie Cope, James G. Herman, George Somlo, Agustin A. García, Peter A. Jones, Stephen B. Baylin, Nancy E. Davidson, Cynthia A. Zahnow, Vered Stearns - Clinical Cancer Research 2016 被引用: 159
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
著者: Hsing-Chen Tsai, Huili Li, Leander Van Neste, Yi Cai, Carine Robert, Feyruz V. Rassool, James Shin, Kirsten Harbom, Robert M. Beaty, Emmanouil P. Pappou, James Harris, Ray-Whay Chiu Yen, Nita Ahuja, Malcolm V. Brock, Vered Stearns, David Feller‐Kopman, Lonny Yarmus, Yi‐Chun Lin, Alana L. Welm, Jean‐Pierre J. Issa, Il Minn, William Matsui, Yoon-Young Jang, Saul J. Sharkis, Stephen B. Baylin, Cynthia A. Zahnow - Cancer Cell 2012 被引用: 647
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
著者: Huili Li, Katherine B. Chiappinelli, Angela A. Guzzetta, Hariharan Easwaran, Ray-Whay Chiu Yen, Rajita Vatapalli, Michael J. Topper, Jianjun Luo, Roisín M. Connolly, Nilofer S. Azad, Vered Stearns, Drew M. Pardoll, Nancy E. Davidson, Peter A. Jones, Dennis J. Slamon, Stephen B. Baylin, Cynthia A. Zahnow, Nita Ahuja - Oncotarget 2014 被引用: 439
- Randomized trial of two artificial intelligence coaching interventions to increase physical activity in cancer survivors
著者: Ahmed Hassoon, Yasmin Baig, Daniel Q. Naiman, David D. Celentano, Dina Lansey, Vered Stearns, Josef Coresh, Jennifer A. Schrack, Seth S. Martin, Hsin-Chieh Yeh, Hadas Zeilberger, Lawrence J. Appel - npj Digital Medicine, npj Digit. Medicine 2021 被引用: 59
- Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
著者: Heather A. Parsons, Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G. Abramson, Ayan R. Patel, Justin Cheng, Adam Brufsky, Justin Rhoades, Jeremy Force, Rong Liu, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Kathy D. Miller, Vered Stearns, Jennifer M. Specht, Carla I. Falkson, Harold J. Burstein, Antonio C. Wolff, Eric P. Winer, Nabihah Tayob, Ian E. Krop, G. Mike Makrigiorgos, Todd R. Golub, Erica L. Mayer, Viktor A. Adalsteinsson - Annals of Oncology 2023 被引用: 57
- Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment
著者: Dimitrios N. Sidiropoulos, Christine I. Rafie, Julie K. Jang, Sofi Castanon, Aaron G. Baugh, Edgar Gonzalez, Brian J. Christmas, Valerie H. Narumi, Emily F. Davis-Marcisak, Gaurav Sharma, Emma Bigelow, Ajay Vaghasia, Anuj Gupta, Alyza Skaist, Michael Considine, Sarah J. Wheelan, Sathish Kumar Ganesan, Min Yu, Srinivasan Yegnasubramanian, Vered Stearns, Roisin M. Connolly, Daria A. Gaykalova, Luciane T. Kagohara, Elizabeth M. Jaffee, Elana J. Fertig, Evanthia T. Roussos Torres - Cancer Immunology Research 2022 被引用: 62
- Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
著者: Evanthia T. Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A. Tandurella, James M. Leatherman, Christine I. Rafie, Chenguang Wang, Adam Brufsky, Patricia LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O’Connor, Sarah M. Shin, Alexei Hernandez, Elizabeth L. Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A. Rudek, Qingfeng Zhu, Robert A. Anders, Ashley Cimino‐Mathews, Elana J. Fertig, Elizabeth M. Jaffee, Vered Stearns, Roisín M. Connolly - Nature Cancer 2024 被引用: 47
- TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
著者: Steven J. Isakoff, Erica L. Mayer, Lei He, Tiffany A. Traina, Lisa A. Carey, Karen J. Krag, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Steven E. Come, Kirsten M. Timms, Anne-Renee Hartman, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, Leif W. Ellisen - Journal of Clinical Oncology 2015 被引用: 430
- Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
著者: Preethi Korangath, Wei Wen Teo, Helen Sadik, Liangfeng Han, Noriko Mori, Charlotte M. Huijts, Flonné Wildes, Santosh Kumar Bharti, Zhe Zhang, Cesar A. Santa‐Maria, Hua‐Ling Tsai, Chi V. Dang, Vered Stearns, Zaver M. Bhujwalla, Saraswati Sukumar - Clinical Cancer Research 2015 被引用: 186
- CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?
著者: Mirat Shah, Maria Raquel Nunes, Vered Stearns - 2018 被引用: 132
- Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
著者: Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan, Rory L. Cochran, Sarah Croessmann, Daniel J. Zabransky, Hong Yuen Wong, Patricia Valda Toro, Justin Cidado, Brian Blair, David Chu, Timothy F. Burns, Michaela J. Higgins, Vered Stearns, Lisa K. Jacobs, Mehran Habibi, Julie R. Lange, Paula J. Hurley, Josh Lauring, Dustin A. VanDenBerg, Jill Kessler, Stacie C. Jeter, Michael L. Samuels, Dianna Maar, Leslie Cope, Ashley Cimino‐Mathews, Pedram Argani, Antonio C. Wolff, Ben Ho Park - Clinical Cancer Research 2014 被引用: 396
- ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
著者: Shani Paluch–Shimon, Fátima Cardoso, Ann H. Partridge, Omalkhair Abulkhair, Hatem A. Azim, G. Bianchi-Micheli, Maria João Cardoso, Giuseppe Curigliano, Karen A. Gelmon, Nadia Harbeck, J. Merschdorf, Philip Poortmans, Giancarlo Pruneri, Elżbieta Senkus, Tanja Španić, Vered Stearns, Yvonne Wengström, Fedro A. Peccatori, Olivia Pagani - Annals of Oncology 2020 被引用: 253
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
著者: Harold J. Burstein, Sarah Temin, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen Gelmon, Sharon H. Giordano, Clifford A. Hudis, Diana Rowden, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2014 被引用: 793
- Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer
著者: N. Lynn Henry, Faouzi Azzouz, Zereunesay Desta, Lang Li, Anne Nguyen, Suzanne Lemler, Jill A. Hayden, Karineh Tarpinian, Elizabeth Yakim, David A. Flockhart, Vered Stearns, Daniel F. Hayes, Anna Maria Storniolo - Journal of Clinical Oncology 2012 被引用: 389
- Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine
著者: Vered Stearns - JNCI Journal of the National Cancer Institute 2003 被引用: 849
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
著者: Harold J. Burstein, Christina Lacchetti, Holly Anderson, Thomas A. Buchholz, Nancy E. Davidson, Karen Gelmon, Sharon H. Giordano, Clifford A. Hudis, Alexander J. Solky, Vered Stearns, Eric P. Winer, Jennifer J. Griggs - Journal of Clinical Oncology 2016 被引用: 303
- Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
著者: Haoyang Mi, Chang Gong, Jeremias Sulam, Elana J. Fertig, Alexander S. Szalay, Elizabeth M. Jaffee, Vered Stearns, Leisha A. Emens, Ashley Cimino‐Mathews, Aleksander S. Popel - Frontiers in Physiology 2020 被引用: 79
- Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
著者: Hanwen Wang, Richard J. Sové, Mohammad Jafarnejad, Sondra Rahmeh, Elizabeth M. Jaffee, Vered Stearns, Evanthia T. Roussos Torres, Roisín M. Connolly, Aleksander S. Popel - Frontiers in Bioengineering and Biotechnology 2020 被引用: 51
